OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-12-31-accounts

Registered number: 02736320 Charity number: 1013557

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

CONTENTS
Page
Reference and administrative details of the charity, its trustees and advisers 1
Trustees' report 2 - 14
Independent examiner's report 15 - 16
Statement of financial activities 17
Balance sheet 18
Notes to the financial statements 19 - 31

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2022

Trustees

Janet Bray, Trustee Professor Andrew Shennan OBE, Chairman Dr Kim Turner, Trustee Dianne Garland, Trustee Rex Delicate, Trustee Dr Carol Cooper, Trustee Vijya Varshani, Trustee Professor Jenny Myers, Trustee Darren Reece, Trustee Dr Carol Lole-Harris, Trustee Rob Crussell, Trustee Andrea Harrington, Trustee Rachel Redman, Trustee Professor Catherine Nelson Piercy, Trustee Dr Lucy MacKillop, Trustee Dr Sarah Winfield, Trustee Dr Anita Banerjee, Trustee

Company registered number

02736320

Charity registered number

1013557

Registered office

The Stables, 80B High Street, Evesham, Worcestershire, WR11 4EU

Page 1

ACTION ON PRE-ECLAMPSIA LIMITED (A company limited by guarantee)

TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2022

Action on Pre-Eclampsia Limited

Registered company number: 02736320 Registered charity number: 1013557

Trustees annual report for the year ended 31st December 2022

The trustees of Action on Pre-eclampsia present their report on account of the year ended 31 December 2022, which also comprises the directors report as required by the Companies Act 2006.

Reference and administrative details

The legal name of the charity is Action on Pre-Eclampsia Limited.

The charity is also known by its operating name APEC and globally as APEC (UK).

The charity’s area of operation and UK charitable registration

The charity is registered with the Charity Commission in England and Wales with charity number 1013557.

Legal structure of the charity

The charity is constituted as a company limited by guarantee, registered under the Companies Act 2006 and its governing document is a memorandum and articles of association under company legislation.

By operation of law, all trustees are directors under the Companies Act 2006 and all directors are trustees under charity legislation and have responsibilities as such under both company and charity legislation.

The trustees are all individuals.

The principal operating address, telephone number and email address of the charity are:

The Stables, 80B High Street, Evesham, Worcestershire, WR11 4EU Telephone 01386 761848 Email info@apec.org.uk Website www.apec.org.uk Social media links https://linktr.ee/apec_uk

The registered office of the charity for companies’ purposes is the same as the operating address as above.

Page 2

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

The trustees in office during the year

The trustees in office on the date the report was approved were:

Professor Andrew Shennan OBE, Chairman Dr Kim Turner, Trustee Dianne Garland, Trustee Dr Carol Cooper, Trustee Vijya Varshani, Trustee Professor Jenny Myers, Trustee Darren Reece, Trustee Dr Carol Lole-Harris, Trustee Rob Crussell, Trustee Dr Lucy MacKillop, Trustee Dr Sarah Winfield, Trustee Dr Anita Banerjee, Trustee

During the year the trustee board had the benefit of the advice of Prof Emeritus James Walker (Honorary Medical Director) Prof Walker attended the board in an advisory and non-voting capacity.

At the Annual General Meeting Dianne Garland, Rob Crussell, Prof Andrew Shennan OBE, Dr Kim Turner retired as trustees, but are eligible for reappointment. Dr Kate Harding and Dr Louise Webster, having been nominated were appointed as Trustees.

Objects and activities of the charity

The purposes of the charity are as set out in its governing document:

• To educate, inform and advise the public and health professionals about the prevalence, nature and risks of pre-eclampsia and eclampsia;

• To campaign for greater public awareness of the disease and for action to improve methods of detection and treatment; and

• To promote the relief of persons who suffer preeclampsia and to relieve the stress of families of such persons.

The main activities undertaken in relation to those purposes during the year

• It is impossible to write this report and ignore the coronavirus pandemic. Like every charity, company, and individual we have been profoundly affected and from the outset Trustees put in place measures to temper the impact, but no-one could have predicted how long and what effect this was going on. Trustees are pleased that during 2022 much of the activity of the charity returned to some form of normal and we are pleased to see a return to most normal activities in 2023. We have seen this as an opportunity to review how we do our activities and where appropriate have made changes.

• During the year we undertook study days for midwives and student midwives. We provided a free elearning package to increase the number of people reached and raised awareness through our social media channels. We are enormously grateful to the institutions, midwifery societies and hospitals who hosted us as well as the very many speakers who volunteered their time.

Page 3

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

• We ran a highly successful online Experts Day online to share knowledge and experience. This was attended by a record number of senior clinicians. This was an opportunity for many of the leading thinkers in the field to come together and discuss progress on research in preeclampsia. We are very grateful for the number of speakers who freely gave their time to this important event which continues to grow in scale and significance year on year. Running the Expert’s Day online has proven to be a successful formula and we anticipate growing and developing this as it is both cost and time effective.

• We offered, and continue to offer, support to families affected by preeclampsia through our helpline, email and social media presence. We offer verbal support, a listening ear, contact with others who have been through similar experiences and immediate referral to experts where needed. This has been especially important when mothers to be have been concerned about symptoms they may be getting. On a number of occasions women have telephoned and afterwards have felt empowered to move forward with their treatment. There have been repeated examples throughout the year when we have been able to refer women who have had problems in the past to experts in the field who have been able to advise them. We remain truly grateful to the world leading experts throughout the UK who have continued to support the helpline activities and been able to advise accordingly.

• We continue to offer support to researchers and trials ensuring that the views of women and families are heard at every level. This year has seen an escalation in the number of trials that we are supporting. In the United Kingdom it is often the case that if you wish to apply for research funding, the voice of the patient has to be heard and we have collaborated as co-investigator on a number of trials as well as providing informal and formal advice to others. During the year we undertook a number of study days for midwives and student midwives. We provided a free elearning package to increase the number of people reached and raised awareness through our social media channels.

Page 4

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

The main activities undertaken during the year to further the charity's purpose for the public benefit

The main activities of the charity have been to

The trustees have had regard to the Charity Commission's guidance on public benefit in managing the activities of the charity.

The main achievements and performance of the charity during the year

Training for Midwives

During the year we held a number of Study Days, these included Essex, Coventry, Birmingham, Worcester and an online day focused on Wales. Our online day proved to be an interesting experiment and we intend to repeat this going forward for midwives in hard to reach areas.

Online Training

After a radical overhaul of the training in 2018 to our training programme online training has bedded in well. The course was written by experts led by trustee Prof Kim Turner and a team who contributed from throughout the world. The course is aimed at midwives, though GP’s and AHP’s have also participated.

This has supported our belief that pre-eclampsia is a global issue and our resources need to be made available freely where they are most needed.

Helpline

Our helpline has continued to offer support primarily to parents; we have seen a considerable rise in contacts over the year. We have attributed this to concern over covid. We have especially seen a growth in calls from fathers to be. Where appropriate calls have been passed to our experts and we thank the very many clinical leaders who have taken cases on our behalf, often at a point of crisis and out of hours.

We have been called in to help on significantly complex problems where parents need support to get reports out of the NHS, especially where a baby has died. These cases require patience and diligence and can take many months of work and support.

We continue to recognize the need for holistic care that includes the whole family and we work to support partners as well as sufferers.

Research

APEC is involved in research into the causes, treatments and development of knowledge about pre-eclampsia. We firmly believe that the patient voice has to be at the heart of research and without it, research is much harder.

We are involved at every stage from study design through to publication and post publication dissemination to a wider audience.

This was a year with many new papers and we were proud to collaborate on the following research outputs.

Page 5

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

Accurate surveillance of maternal deaths is an international priority

Published in BMJ 2022; 379 doi: https://doi.org/10.1136/bmj.o2691 (Published 16 November 2022) Andrew H Shennan, Marcus Green, Alexandra E Ridout

Placental growth factor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspected pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)

Alice Hurrell, Jenie Sparkes, Kate Duhig, Paul T Seed, Jenny Myers, Cheryl Battersby, Katherine Clark, Marcus Green, Rachael M Hunter, Andrew H Shennan, Lucy C Chappell, Louise Webster

Published in PubMed September 22 2022

Risk factors for pre-eclampsia in clinical practice guidelines: comparison with the evidence

Terteel Elawad, Georgia Scott, Jeffrey N. Bone, Helen Elwell, Cristina Escalona Lopez, Veronique Filippi, Marcus Green, Asma Khalil, Mai-Lei W. Kinshella, Hiten D. Mistry, Kelly Pickerill, Reshma Shanmugam, Joel Singer, Rosemarie Townsend, Eleni Z. Tsigas, Marianne Vidler, Marie-Laure Volvert, Peter von Dadelszen, Laura A. Magee

Published in BJOG: An International Journal of Obstetrics & Gynaecology September 2022

Implementation of a novel shared decision-making intervention in women with chronic hypertension in pregnancy: multiple-site multiple-method investigation

Rebecca Whybrow, Jane Sandall, Joanna Girling, Heather Brown, Paul T Seed, Marcus Green, Sarah Findlay, Louise Webster, Lucy C Chappell

Published in Pregnancy Hypertension, September 2022

A Quality framework for remote antenatal care: qualitative study with women, healthcare professionals and system-level stakeholders

Lisa Hinton, Francesca H Dakin, Karolina Kuberska, Nicola Boydell, Janet Willars, Tim Draycott, Cathy Winter, Richard J McManus, Lucy C Chappell, Sanhita Chakrabarti, Elizabeth Howland, Jenny George, Brandi Leach, Mary Dixon-Woods

Published in the BMJ May 2022

Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy – The BUMP 1 Randomized Clinical Trial

Katherine L. Tucker, Sam Mort, Ly-Mee Yu, Helen Campbell, Oliver Rivero-Arias, Hannah M. Wilson, Julie Allen, Rebecca Band, Alison Chisholm, Carole Crawford, Greig Dougall, Lazarina Engonidou, Marloes Franssen, Marcus Green, Sheila Greenfield, Lisa Hinton, James Hodgkinson, Layla Lavallee, Paul Leeson, Christine McCourt, Lucy Mackillop, Jane Sandall, Mauro Santos, Lionel Tarassenko, Carmelo Velardo, Lucy Yardley, Lucy C. Chappell, Richard J. McManus

Published in Journal of the American Medical Association May 2022

Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension – The BUMP 2 Randomized Clinical Trial

Lucy C. Chappell, Katherine L. Tucker, Ushma Galal, Ly-Mee Yu, Helen Campbell, Oliver Rivero-Arias, Julie Allen, Rebecca Band, Alison Chisholm, Carole Crawford, MSc; Greig Dougall, Lazarina Engonidou, Marloes Franssen, Marcus Green, Sheila Greenfield, Lisa Hinton, James Hodgkinson, Layla Lavallee, Paul Leeson, Christine McCourt, Lucy Mackillop, Jane Sandall, Mauro Santos, Lionel Tarassenko, Carmelo Velardo, Hannah Wilson, Lucy Yardley, PhD; Richard J. McManus

Published in Journal of the American Medical Association May 2022

Page 6

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

Planned delivery or expectant management in pre-eclampsia: an individual participant data metaanalysis

Alice Beardmore-Gray, Paul T. Seed, Jessica Fleminger, Eva Zwertbroek, Thomas Bernardes, Ben W.Mol, Cheryl Battersby, Corine Koopmans, Kim Broekhuijsen, Kim Boers, Michelle Y.Owens, JimThornton, Marcus Green, Andrew H.Shennan, Henk Groen, Lucy C.Chappell

Published in American Journal of Obstetrics and Gynaecology, 26th April 2022

https://doi.org/10.1016/j.ajog.2022.04.034

Two-year follow-up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial

Alice Beardmore-Gray, Melanie Greenland, Louise Linsell, Edmund Juszczak, Pollyanna Hardy, Anna Placzek, Rachael Hunter, Jenie Sparkes, Marcus Green, Andrew H Shennan, Neil Marlow, Lucy C Chappell

Published in BJOG An International Journal of Obstetrics & Gynaecology April 2022 DOI:10.1111/1471-0528.17167

Postnatal health and care following hypertensive disorders in pregnancy: a prospective cohort study (BPiPP study)

Danielle Ashworth, Liza Bowen, Paul T. Seed, Sophie P. Maule, Marcus Edward Green, Debra E Bick, Lucy C. Chappell

Published in BMC Pregnancy and Childbirth 22(1) April 2022

Paracetamol use in pregnancy — neglecting context promotes misinterpretation

Joseph O’Sullivan, Alexandra E. Cairns, Elena Plesca, Rebecca S. Black, Charlotte Frise, Manu Vatish and Ana Sofia Cerdeira

Published in Nature Reviews Endocrinology March 2022

PMID: 35277662DOI:

Which antihypertensive treatment is better for mild to moderate hypertension in pregnancy?

Danielle Ashworth, Cheryl Battersby, Marcus Green, Pollyanna Hardy, Richard J McManus, Catherine Cluver, Lucy C Chappell,

Published in BMJ 2022; 376 18th January 2022

BMJ 2022;376:e066333

Full details can be found in the new research portal of our website https://action-on-pre eclampsia.org.uk/research/

Experts Day

The pandemic meant that alongside everything else our Experts Meeting needed to be taken online. This was done via Zoom and we are very grateful to James Howie for his help with technical aspects and making for a flawless presentation.

Taking the meeting online meant we had over 250 delegates from throughout the world sign up from a wide variety of institutions from throughout the world. This meeting is rapidly becoming the UK meeting on hypertension in pregnancy and the attendance was in line with the previous year.

Speakers included Dr Antonio de Marvao, Alice Clements, Olivia Moran, Lilja Thorgeirsdottir, Layla Lavallee, Dr Tamara Kubba, Lucy Goddard, Nicola Solomon, Olivia Jones, Raya Vinogradov, Dr Shireen Meher, Dr Bernadette Jenner, Veronica Giorgione, Prof Liona Poon, Prof Chris Redman, Isabel Walker, Prof David

Page 7

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

Williams, Prof Basky Thilaganathan, Prof Laura Magee, Prof Alex Heazell, Prof Peter Brocklehurst, Prof Asma Khalil, Prof Jenny Myers, Dr Anita Banerjee and the keynote speaker was Prof Lucy Chappell, the Chief Scientific Advisor to the Department of Health.

Feedback was hugely positive.

External Bodies, publications and campaigns

We continued to be involved in baby loss awareness week which goes from strength to strength. One of the main events of the week is the parliamentary discussion in the chamber of the House of Commons where once again action on preeclampsia was mentioned.

We have continued to campaign for greater take up of PIGF testing, especially in the devolved administrations and saw slight progress in Wales and Scotland.

We have continued to enjoy close working relationships with other baby charities through the Pregnancy and Baby Charities Network. The principal outcome from this work has been a manifesto which sets out what the charities would hope from any government. There have also been a wide range of meetings with politicians and others especially within the National Health Service where collaborative working has meant we are able to achieve more than we would as individual charities.

As a direct result of this we have expanded the reach of our study days and now try to have a talk either from ICP support or Group B Strep Support.

In May APEC took part in the world preeclampsia day where we coordinated a number of activities and raised the profile significantly for both the day and the charity.

We have continued to work closely alongside the ISOM, ISSHP and McDonald Obstetric Medicine Society and appreciate these collaborations which are mutually beneficial.

The charity has also been involved in a whole host of other organizations, conferences, papers and media articles.

Worldwide Activities

We have worked with patient participation groups in the United States, Australia, New Zealand and in Ghana. We also participated in the World Pre-Eclampsia Day which was a great success. We worked especially closely with APEC in Ghana who continue to grow from strength to strength.

Redman Walker Award

The charity set up the Redman Walker award in 2017. This designated fund of £20,000 has been designed to recognise the efforts of young researchers. The award will work on an annual cycle with up to two awards of £500.

Staffing

For the APEC staff 2022 presented numerous ongoing challenges due to the pandemic. We had set out an ambitious set of plans for the year and delivered on them.

Staff very rapidly became used to daily Zoom meetings which have continued throughout and there has been considerable learning about how we can be more agile in delivering the services.

Page 8

ACTION ON PRE-ECLAMPSIA LIMITED (A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

The Trustees are immensely grateful to the staff for going beyond the call of duty this year. It is appreciated. We have continued to campaign for greater take up of PIGF testing, especially in the devolved administrations.

Fundraising activities during the year

APEC’s principal fundraising activity was the London Marathon where a large number of individuals once again ran for the charity. We are immensely grateful to those runners who made a massive contribution.

Our members have been generous in their support which is so gratefully received. We continue to rely on voluntary donations for virtually all our income.

During the pandemic we facilitated the sale of Cradle Blood Pressure devices to NHS trusts and others.

For our Christmas appeal we partnered with The Big Give and the results were excellent.

We are grateful to all our donors especially the trusts listed below.

TRUSTS 2022

Eveson £3,000 Edgar Lawley £1,500 Sovereign £1,000 Steel £5,000 Wychavon small grants £2,000 The Big Give £15,400 £27,900

The difference the charity's performance during the year has made to the beneficiaries of the charity

During the year we have received some very positive feedback from those who have been in contact with our charity. A number of examples of this are shown below:

One mother, whose first child was born with a long term health condition as a result of pre-eclampsia accessed the APEC helpline several times during lockdown and was referred by us to a specialist in pre-eclampsia sent us a letter. She wrote:

“Without your compassion, efficiency, urgency and professionalism, we would never have got in touch with the team at (the hospital). We want you to know you played an integral part in our pregnancy and reassuring us that we were in the right hands. Fortunately for us, our second pregnancy was so well managed that we didn’t have to encounter any of the difficulty of the first. A safe, healthy delivery, even during a global pandemic is what we got!

We wanted to say thank you and to pass on how important the work you and the charity do. You were the first person that truly heard me.”

“I thought I would share our latest family news with you both, my partner is 13 weeks pregnant. Without APEC and the support you and the wider APEC community have given us we would not be in this position. It is a huge thank you from us both.”

Page 9

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

Delegates gave feedback from APEC events

“I think staff won't maybe understand how useful this is...you need to have this insight. More maternity based cases would be very interesting too though.”

“Very useful - complex guideline explained well” “Excellent”

“Wish we had more time”

“Thank you to Andy Shennan for being approachable and kind in addition to knowledgeable.”

STRUCTURE, GOVERNANCE AND MANAGEMENT OF THE CHARITY

The methods used to recruit and appoint new charity trustees

The charity is a company and charity and follows the legislation pertaining to both. The charity is governed by its Articles and Memorandum in a trust document from 1992. Trustees are satisfied that these documents meet the needs of the charity, now and into the future.

Trustees are appointed from within the membership. The governing document allows for between 5 and 13 trustees and there are currently 15. A vote at the AGM in 2020 allowed for a wider trustee board during the pandemic and in the aftermath.

To appoint trustees, APEC follow the Charity Commission guidelines. Specifically, we:

Page 10

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

The trustees' bankers and advisors

Bankers

The Cooperative Bank, 1 Balloon Street, Manchester M60 4EP CAF Bank Limited, 25 Kings Hill Avenue, Kings Hill, West Malling, Kent ME19 4JQ Royal Bank Of Scotland, RBS Business Banking, PO Box 16204, Birmingham, B2 2WP

Accountants

Donald Reid Limited, Prince Albert House, 20 King Street, Maidenhead, Berkshire, SL6 1DT.

Solicitors

Saunders Roberts 1 Crown Court Yard, Bridge Street, Evesham, Worcestershire, WR11 4RY.

Financial review

Financial review of the position at the reporting date, 31 December 2022.

The charity made a surplus of £44,827 compared with a surplus of £14,033 in 2021.

This result reflected the exceptional result in the previous year when increased sales of blood pressure monitors contributed greatly.

The trustees consider the financial performance by the charity during the year to have been satisfactory. The trustees also consider the charity to be solvent and financially sound as at 31 December 2022. The principal sources of funding for the charity come from fundraising, training courses and donations. The principal risks and uncertainties relate to certainty of funding, trustees monitor and review this and other operational/strategic risks.

Policies on reserves

In the trustees’ view, the reserves should provide the charity with adequate financial stability and the means for it to meet its charitable objectives for the foreseeable future.

The trustees propose to maintain the charity’s reserves at a level which is at least equivalent to six months operational expenditure and have done so having regards to its manner of operation of likely funding streams.

The trustees review the amount of reserves that are required to ensure that they are adequate to fulfil the charity’s continuing obligations on a quarterly basis at their trustee meeting.

Trustees are content that reserves are at a satisfactory level given the size, scope and risks to the charity at the current time. The trustees plan that the charity is a going concern and have no uncertainties other than managed risks about this.

The current reserves are in excess of the stated policy however, this reflects the generous support we received in the first year of the pandemic, trustees consider that 2022 and 2023 could be harder years for fundraising and therefore are maintaining a higher level of reserves than they would otherwise.

Availability and adequacy of assets of each of the funds

The board of trustees is satisfied that the charity's assets in each fund are available and adequate to fulfil its obligations in respect of each fund.

Page 11

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

Plans for the Future

The charity is aware that a surplus has built up and is keen to ensure monies are used for our charitable purposes and therefore is, as of autumn 2023, reviewing how we can best meet the needs of those we are here to support. Trustees expect a new strategy to emerge in early 2024 which will address this.

Employment of disabled persons

During the year we did not take any new members of staff on and employ just two individuals who are part time. Should we have a vacancy arising in the future we would ensure that all equality legislation is followed correctly. At the year end Carol Tustin retired and an open recruitment process ensured the best candidate for the job was appointed.

Details of the Independent Examiner

Daniel Reid FCA Donald Reid Limited Chartered Accountants Prince Albert House 20 King Street Maidenhead Berkshire SL6 1DT

Page 12

ACTION ON PRE-ECLAMPSIA LIMITED (A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

Statement of Directors' and Trustees' Responsibilities

The charity's trustees are responsible for the preparation of the accounts in accordance with the terms of the Companies Act 2006, Charities Act 2011 and the Charities (Accounts and Reports) Regulations 2008.

Notwithstanding the explicit requirement in the extant statutory regulations, the Charities (Accounts and Reports) Regulations 2008, to prepare the financial statements in accordance with the SORP 2005, in view of the fact that the SORP 2005 has been withdrawn, the determined to interpret this responsibility as requiring them to follow current best practice and prepare the accounts according to the FRS 102 SORP 2019.

In particular, the Companies Act 2006 and charity law require the Board of Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity as at the end of the financial year and of the surplus or deficit of the charity. In preparing those financial statements the Board is required to:

• prepare the accounts in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law);

• select suitable accounting policies and then apply them consistently;

• make judgements and estimates that are reasonable and prudent;

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business; and

• state whether applicable accounting standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements.

The law requires that the trustees must not approve the accounts unless they are satisfied that they give a true and fair view of the state of affairs of the charity and of the surplus or deficit of the charity for the year.

The Trustees are also responsible for maintaining adequate accounting records which disclose with reasonable accuracy at any time the financial position of the charity and which are sufficient to show and explain the charity's transactions and enable them to ensure that the financial statements comply with the Companies Act 2006 and comply with regulations made under the Charities Act. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The Trustees are also responsible for the contents of the Trustees' report, and the statutory responsibility of the Independent Examiner in relation to the Trustees' report is limited to examining the report and ensuring that, on the face of the report, there are no material inconsistencies with the figures disclosed in the financial statements.

Page 13

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

Method of preparation of accounts - Small company provisions

The financial statements are set out on pages 17 to 31.

The financial statements have been prepared implementing the Statement of Recommended Practice for Accounting and Reporting by Charities 2015 and in accordance with the Financial Reporting Standard for Smaller Entities 2015.

These accounts have been prepared in accordance with the provisions in Part 15 of the Companies Act 2006 applicable to companies subject to the small company’s regime.

This report was approved by the board of trustees on 11 September 2023 and signed on their behalf by

Professor Andrew Shennan

Director and Chair of Trustees

Page 14

ACTION ON PRE-ECLAMPSIA LIMITED (A company limited by guarantee)

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2022

Independent Examiner's Report to the Trustees of Action on Pre-Eclampsia Limited (the 'charity')

I report to the charity Trustees on my examination of the accounts of the charity for the year ended 31 December 2022.

This report is made solely to the charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the charity's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charity and the charity's Trustees as a body, for my work or for this report.

Responsibilities and Basis of Report

As the Trustees of the charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent Examiner's Statement

I have completed my examination. I can confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

Page 15

ACTION ON PRE-ECLAMPSIA LIMITED (A company limited by guarantee)

INDEPENDENT EXAMINER'S REPORT (continued) FOR THE YEAR ENDED 31 DECEMBER 2022

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Signed:

Dated:

Daniel Reid FCA

Donald Reid Limited Chartered Accountants Prince Albert House 20 King Street Maidenhead Berkshire SL6 1DT

Page 16

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

STATEMENT OF FINANCIAL ACTIVITIES INCORPORATING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2022

Unrestricted
funds
Note
2022
£
Income from:
Donations and legacies
2
71,287
Other trading activities:
Fundraising
3
94,438
Trading activities
4
33,517
Investments
5
317
Total income
199,559
Expenditure on:
Raising funds:
Voluntary income
15,379
Fundraising trading
4
12,230
Other charitable activities
127,123
Total expenditure
9
154,732
Net income before other recognised gains and losses
44,827
Net movement in funds
44,827
Reconciliation of funds:
Total funds brought forward
178,334
Total funds carried forward
223,161		 Total
funds
2022
£
71,287
94,438
33,517
317
199,559
15,379
12,230
127,123
154,732
44,827
44,827
178,334
223,161		 Total
funds
2021
£
93,033
30,600
28,392
6
152,031
3,805
20,970
113,253
138,028
14,003
14,003
164,331
178,334

The notes on pages 19 to 31 form part of these financial statements.

Page 17

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee) REGISTERED NUMBER: 02736320

BALANCE SHEET AS AT 31 DECEMBER 2022

Note
Fixed assets
Tangible assets
14
Current assets
Stocks
15
Debtors
16
Cash at bank and in hand
Creditors:amounts falling due within one
year
17
Net current assets
Net assets
Charity Funds
Unrestricted funds
18
Total funds		 £
1,875
14,828
207,456
224,159
(1,559)		 2022
£
561
222,600
223,161
223,161
223,161		 £
4,328
6,823
168,920
180,071
(2,160)		 2021
£
423
177,911
178,334
178,334
178,334

The charity's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The Trustees consider that the charity is entitled to exemption from the requirement to have an audit under the provisions of section 477 of the Companies Act 2006 ("the Act") and members have not required the charity to obtain an audit for the year in question in accordance with section 476 of the Act.

The Trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements were approved and authorised for issue by the Trustees on 11 September 2023 and signed on their behalf, by:

Professor Andrew Shennan, Chairman

The notes on pages 19 to 31 form part of these financial statements.

Page 18

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

1. Accounting Policies

1.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Action on Pre-Eclampsia Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

1.2 Company status

The charity is a company limited by guarantee. The members of the company are the Trustees named on page 1. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity.

1.3 Income

All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

For legacies, entitlement is taken as the earlier of the date on which either: the charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor(s) to the Trust that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the charity has been notified of the executor's intention to make a distribution. Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material.

Donated services or facilities are recognised when the charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use of the charity of the item is probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FRS 102), the general volunteer time of friends is not recognised.

On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

Page 19

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

1. Accounting Policies (continued)

1.4 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities. Support costs are those costs incurred directly in support of expenditure on the objects of the charity and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the charity and compliance with constitutional and statutory requirements.

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

Charitable activities and Governance costs are costs incurred on the charity's educational operations, including support costs and costs relating to the governance of the charity apportioned to charitable activities.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

All expenditure is inclusive of irrecoverable VAT.

1.5 Turnover

Turnover comprises revenue recognised by the charity in respect of goods and services supplied during the year, exclusive of Value Added Tax and trade discounts.

1.6 Tangible fixed assets and depreciation

A review for impairment of a fixed asset is carried out if events or changes in circumstances indicate that the carrying value of any fixed asset may not be recoverable. Shortfalls between the carrying value of fixed assets and their recoverable amounts are recognised as impairments. Impairment losses are recognised in the Statement of financial activities incorporating income and expenditure account.

Tangible fixed assets are carried at cost, net of depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant and machinery

Page 20

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

1. Accounting Policies (continued)

1.7 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the Bank.

1.8 Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks.

1.9 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

1.10 Cash at Bank and in hand

Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

1.11 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Liabilities are recognised at the amount that the charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide. Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised within interest payable and similar charges.

1.12 Financial instruments

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

1.13 Pensions

The charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the charity to the fund in respect of the year.

Page 21

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

1. Accounting Policies (continued)

1.14 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

2. Income from donations and legacies

Unrestricted
funds
2022
£
Donations
57,787
Grants
9,500
Sponsorship
4,000
Total donations and legacies
71,287
Total 2021
93,033
Fundraising income
Unrestricted
funds
2022
£
Marathon income and other fundraising events
94,438
94,438
Total 2021
30,600		 Total
funds
2022
£
57,787
9,500
4,000
71,287
93,033
Total
funds
2022
£
94,438
94,438
30,600		 Total
funds
2021
£
55,512
16,746
20,775
93,033
Total
funds
2021
£
30,600
30,600

3. Fundraising income

Page 22

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

4. Trading activities

Unrestricted
funds
2022
£
Charity trading income
Charity trading income - Blood pressure monitors and
books
33,517
33,517
Fundraising trading expenses
Purchases
11,299
Miscellaneous fundraising costs
931
12,230
Net income from trading activities
21,287
Investment income
Unrestricted
funds
2022
£
Investment income - bank interest receivable
317
Total 2021
6		 Total
funds
2022
£
33,517
33,517
11,299
931
12,230
21,287
Total
funds
2022
£
317
6		 Total
funds
2021
£
28,392
28,392
20,970
-
20,970
7,422
Total
funds
2021
£
6

5. Investment income

Page 23

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

6. Direct costs

Unrestricted
funds
£
International development
3,510
Travel and subsistence
1,839
Marketing and advertising of charitable
services
1,260
Expert meetings and study day costs
410
Website
4,624
Leaflet costs
100
Wages and salaries
25,308
Pension cost
733
37,784
Total 2021
27,891
Support costs
Unrestricted
funds
£
IT support
2,720
Rent payable under operating leases
6,000
Light, heat and power
2,427
Telephone, fax and internet
847
Stationery and printing
1,061
Liability and contents insurance
519
Resource costs
1,818
Management consultancy
60,462
Staff training
280
Wages and salaries
8,416
Pension cost
244
Depreciation and loss on disposal of fixed
assets
149
84,943
Total 2021
80,875		 Total
2022
£
3,510
1,839
1,260
410
4,624
100
25,308
733
37,784
27,891
Total
2022
£
2,720
6,000
2,427
847
1,061
519
1,818
60,462
280
8,416
244
149
84,943
80,875		 Total
2021
£
-
630
-
-
2,209
-
24,425
627
27,891
Total
2021
£
1,524
5,720
1,984
1,351
1,646
84
1,404
57,929
-
8,346
209
678
80,875

7. Support costs

Page 24

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

8. Governance costs

Unrestricted
funds
2022
£
Governance - accountancy and independent examination
4,187
Legal and professional fees
35
Bank charges
73
Governance - Trustees' expenses reimbursed
101
4,396
Analysis of Expenditure by expenditure type
Staff costs
Depreciation
Other costs
2022
£
2022
£
2022
£
Expenditure on raising
voluntary income
-
-
15,379
Expenditure on fundraising
trading
-
-
12,230
Costs of raising funds
-
-
27,609
Direct and support costs
34,701
149
87,877
Expenditure on governance
-
-
4,396
34,701
149
119,882
Total 2021
33,607
678
103,743		 Total
funds
2022
£
4,187
35
73
101
4,396
Total
2022
£
15,379
12,230
27,609
122,727
4,396
154,732
138,028		 Total
funds
2021
£
3,739
188
60
-
3,987
Total
2021
£
3,805
20,970
24,775
109,266
3,987
138,028

9. Analysis of Expenditure by expenditure type

10. Turnover

All turnover arose within the United Kingdom.

Page 25

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

11. Net income/(expenditure)

This is stated after charging:

2022 2021
£ £
Depreciation of tangible fixed assets:
- owned by the charity 149 290
Loss on disposal of fixed assets - 388

During the year, no Trustees received any remuneration (2021 - £NIL). During the year, no Trustees received any benefits in kind (2021 - £NIL).

1 Trustee received reimbursement of expenses amounting to £101 in the current year, (2021 - 0 Trustees - £NIL).

12. Independent Examiner's remuneration

The Independent Examiner's remuneration amounts to an Independent Examination fee of £1,080 (2021 - £1,080), and accountancy of £2,400 (2021 - £2,400).

Page 26

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

13. Staff costs

Staff costs were as follows:

Wages and salaries
Other pension costs		 2022
£
33,724
977
34,701		 2021
£
32,771
836
33,607

The average number of persons employed by the charity during the year was as follows:

Engaged on fundraising activities
Engaged on management and administration		 2022
No.
1
1
2		 2021
No.
1
1
2

No employee received remuneration amounting to more than £60,000 in either year.

14. Tangible fixed assets

Cost
At 1 January 2022
Additions
At 31 December 2022
Depreciation
At 1 January 2022
Charge for the year
At 31 December 2022
Net book value
At 31 December 2022
At 31 December 2021		 Plant and
machinery
£
674
287
961
251
149
400
561
423

Page 27

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

15. Stocks

15.
Stocks
Finished goods and goods for resale
16.
Debtors
Other debtors
Prepayments and accrued income
17.
Creditors: Amounts falling due within one year		 2022
£
1,875
2022
£
4,693
10,135
14,828		 2021
£
4,328
2021
£
2,565
4,258
6,823
Creditors: Amounts falling due within one year
2022 2021
£ £
Accruals and deferred income 1,559 2,160

18. Statement of funds

Statement of funds - current year

Designated funds
Designated Funds - all funds
General funds
General Funds - all funds
Total Unrestricted funds
Total of funds		 Balance at
1 January
2022
£
19,500
158,834
178,334
178,334		 Income Expenditure
£
£
-
-
199,559
(154,732)
199,559
(154,732)
199,559
(154,732)		 Balance at
31
December
2022
£
19,500
203,661
223,161
223,161

Redman Walker Award fund

The charity set up the Redman Walker award in 2017. The trustees have created a designated fund of £20,000 in order to finance the Redman Walker Award, which has been designed to recognise the efforts of young researchers. The award will work on an annual cycle with up to two awards of £500.

Page 28

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

18. Statement of funds (continued)

Statement of funds - prior year

Designated Funds - all funds
General Funds - all funds
Total of funds
Summary of funds - current year
Designated funds
General funds
Summary of funds - prior year
Designated funds
General funds		 Balance at
1 January
2021
£
20,000
144,331
164,331
Balance at
1 January
2022
£
19,500
158,834
178,334
Balance at
1 January
2021
£
20,000
144,331
164,331		 Income
Expenditure
£
£
-
(500)
152,031
(137,528)
152,031
(138,028)
Income Expenditure
£
£
-
-
199,559
(154,732)
199,559
(154,732)
Income
Expenditure
£
£
-
(500)
152,031
(137,528)
152,031
(138,028)		 Balance at
31
December
2021
£
19,500
158,834
178,334
Balance at
31
December
2022
£
19,500
203,661
223,161
Balance at
31
December
2021
£
19,500
158,834
178,334

Page 29

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

19. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2022
£
Tangible fixed assets
561
Current assets
224,159
Creditors due within one year
(1,559)
223,161
Analysis of net assets between funds - prior year
Unrestricted
funds
2021
£
Tangible fixed assets
423
Current assets
180,071
Creditors due within one year
(2,160)
178,334		 Total
funds
2022
£
561
224,159
(1,559)
223,161
Total
funds
2021
£
423
180,071
(2,160)
178,334

Page 30

ACTION ON PRE-ECLAMPSIA LIMITED

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022

20. Pension commitments

The charity operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the charity in an independently administered fund. The pension cost charge represents contributions payable by the charity to the fund and amounted to £977 (2021 - £836). No contributions were payable to the fund at the balance sheet date at either the current or prior period end.

Page 31